Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 3;100(11):adv00138.
doi: 10.2340/00015555-3493.

Melanoma Genomics

Review

Melanoma Genomics

Julia Newton-Bishop et al. Acta Derm Venereol. .

Abstract

The incidence of cutaneous melanoma continues to increase in pale skinned peoples in Europe and elsewhere. Epidemiological studies identified genetically determined phenotypes such as pale skin, freckles and red hair, and sunburn as risk factors for this cancer. The development of many melanocytic naevi is also genetically determined and a strong melanoma risk phenotype. Not surprisingly then, genome wide association studies have identified pigmentation genes as common risk genes, and to a lesser extent, genes associated with melanocytic naevi. More unexpectedly, genes associated with telomere length have also been identified as risk genes. Higher risk susceptibility genes have been identified, particularly CDKN2A as the most common cause, and very rarely genes such as CDK4, POT1, TERT and other genes in coding for proteins in the shelterin complex are found to be mutated. Familial melanoma genes are associated with an increased number of melanocytic naevi but not invariably and the atypical naevus phenotype is therefore an imperfect marker of gene carrier status. At a somatic level, the most common driver mutation is BRAF, second most common NRAS, third NF1 and increasing numbers of additional rarer mutations are being identified such as in TP53. It is of note that the BRAF and NRAS mutations are not C>T accepted as characteristic of ultraviolet light induced mutations.

Keywords: melanoma; somatic mutations; susceptibility genes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Incidence rates for melanoma in men in two genetically similar populations in England and in Australia. The figures were generated on line using the Globocan tool (gco.iarc.fr).
Fig. 2
Fig. 2
Principal components analysis (PCA) from a genome-wide association study reported by the GenoMEL consortium (2). The coloured dots represent a measure of the genetic inheritance of participants in a genetic study of melanoma. The superimposed blue, green and terracotta dots over the UK suggests that the participants from two sites in Australia (Sydney and Brisbane) were very similar genetically to those living in the UK. This was expected as many Australian melanoma patients report ethnicity as the UK. Comparing incidence in melanoma then between the UK and Australia is to some degree comparing incidence in two populations similar genetically but with very different sun exposure histories. Figure kindly prepared by Dr Mark Iles of the University of Leeds.

Similar articles

Cited by

References

    1. Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, et al. . Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 2018; 92: 108–118. - PubMed
    1. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, et al. . Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009; 41: 920–925. - PMC - PubMed
    1. Wang Y, Zhao Y, Ma S. Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer 2016; 16: 691. - PMC - PubMed
    1. Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. . A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer 2009; 124: 420–428. - PMC - PubMed
    1. Easton D, Cox G, Macdonald A, Ponder B. Genetic susceptibility to naevi – a twin study. Br J Cancer 1991; 64: 1164–1167. - PMC - PubMed

MeSH terms

Substances